Sauget Facility Hours

Monday - Friday              7am - 4pm
Saturday & Sunday           Closed for Inbounds

Crysalis: Bioprocess Transformation

Turnkey Bio-Manufacturing

Crysalis is a bioprocess technology demonstration, manufacturing, and licensing company. We implement our proprietary portfolio of Intellectual Property and proven capabilities to design, build, and operate turnkey biochemical plants. Crysalis is a leader in manufacturing the next generation of low Carbon Intensity (CI) biofuels and biochemicals.

Turnkey Bio-Manufacturing

Crysalis is a bioprocess technology demonstration, manufacturing, and licensing company. We implement our proprietary portfolio of Intellectual Property and proven capabilities to design, build, and operate turnkey biochemical plants. Crysalis is a leader in manufacturing the next generation of low Carbon Intensity (CI) biofuels and biochemicals.

Press Releases

 

September 30 2024

Crysalis Biosciences Inc. Invests $239.5 Million for Sustainable Aviation Fuel Facility in Sauget

Sauget, IL, United States, September 5, 2024 — Governor JB Pritzker, Crysalis Biosciences Inc. and the Illinois Department of Commerce and Economic Opportunity (DCEO) today announced a Reimagining Energy and Vehicles in Illinois (REV Illinois) agreement for Crysalis’ $239.5 million investment to develop a first-of-its-kind sustainable aviation fuel (SAF) plant. The investment, which creates at least 35 new jobs in Sauget, will transform the fuel and chemical industry while reducing the carbon footprint in Illinois by manufacturing SAF, an alternative jet fuel made with a smaller carbon footprint.

Read Full Press Release >

 

 

August 5 2024

Crysalis Biosciences Announces Significant Milestones and Closure of Investment from SAFFA Fund I, LP, anchored by Airbus

Sauget, IL, United States, August 5, 2024 — Crysalis Biosciences Inc., a pioneering biochemicals manufacturing company, announced the achievement of several key milestones and the successful closure of an investment by Airbus, marking a significant step forward in the company’s mission to manufacture zero carbon biochemicals creating green chemical manufacturing infrastructure in the United States.

Read Full Press Release >

 

 

July 23 2024

Airbus and partners invest in Sustainable Aviation Fuel financing fund

Farnborough, United Kingdom, 23 July 2024 — Airbus, the Air France-KLM Group, Associated Energy Group, LLC, BNP Paribas, Burnham Sterling, Mitsubishi HC Capital Inc. and Qantas Airways Limited co-invested in a Sustainable Aviation Fuel (SAF) financing fund to accelerate the production of SAF.

Read Full Press Release >

 

 

May 15 2023

Bio-based Transformation of Organic Solvents for Achieving Carbon Neutrality

Nitto Denko Corporation (hereinafter referred to as “Nitto”) is pleased to announce that it has signed a contract with Crysalis Biosciences Inc., (hereinafter referred to as “Crysalis”) to jointly develop plant-derived acetonitrile as a bio-based solvent, as well as to invest in Crysalis, as part of its efforts to achieve carbon neutrality.

Read Full Press Release >

 

Sign Up For Our News

Enter your email to receive the latest Crysalis news.

Sign Up For Our News

Enter your email to receive the latest Crysalis news.

Current Flagship Projects

Sustainable Aviation Fuel

Crysalis recently purchased a 55 Mgal/yr ethanol facility in Sauget, Illinois. We are transforming this 57-acre asset from conventional fuel ethanol production to a 30 Mgal/yr Sustainable Aviation Fuel (SAF) production facility. This $200 MM project applies our intellectual property portfolio with plant design and construction capabilities to retrofit this plant to produce low carbon intensity SAF.

Sustainable
Aviation Fuel

Crysalis recently purchased a 55 Mgal/yr ethanol facility in Sauget, Illinois. We are transforming this 57-acre asset from conventional fuel ethanol production to a 30 Mgal/yr Sustainable Aviation Fuel (SAF) production facility. This $200 MM project applies our intellectual property portfolio with plant design and construction capabilities to retrofit this plant to produce low carbon intensity SAF.

Low-Carbon Acetonitrile:
Crysalis and Nitto Denko Innovation

An increase in the global demand for acetonitrile is emerging, driven by its applications within the pharmaceutical industry and as a solvent for next-generation batteries. Crysalis and Nitto Denko Corporation are partnering to design and build the world’s first bio-based low carbon intensity acetonitrile plant. This 5 kTa/yr bio-acetonitrile plant will help support the world-wide demand for acetonitrile.

©2024 Crysalis Biosciences, Inc.